Inatomi N[au] - Search Results

Year	Number of Results
1972	1
1973	1
1974	2
1975	1
1977	1
1979	1
1980	1
1983	1
1985	3
1986	1
1987	1
1989	6
1990	3
1991	3
1993	2
1995	2
1996	5
1997	2
2000	2
2001	1
2002	2
2005	1
2008	1
2010	1
2011	6
2012	7
2014	1
2015	2
2016	4
2017	3
2018	2
2019	1
2020	1
2021	1
2022	0

1

[Motilide, motilin-like macrolides].

Omura S, Inatomi N, Itoh Z. Omura S, et al. Among authors: inatomi n. Tanpakushitsu Kakusan Koso. 1993 Aug;38(11):1881-90. Tanpakushitsu Kakusan Koso. 1993. PMID: 8210432 Review. Japanese. No abstract available.

2

Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.

Inatomi N, Matsukawa J, Sakurai Y, Otake K. Inatomi N, et al. Pharmacol Ther. 2016 Dec;168:12-22. doi: 10.1016/j.pharmthera.2016.08.001. Epub 2016 Aug 8. Pharmacol Ther. 2016. PMID: 27514776 Free article. Review.

3

Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).

Otake K, Sakurai Y, Nishida H, Fukui H, Tagawa Y, Yamasaki H, Karashima M, Otsuka K, Inatomi N. Otake K, et al. Among authors: inatomi n. Adv Ther. 2016 Jul;33(7):1140-57. doi: 10.1007/s12325-016-0345-2. Epub 2016 Jun 10. Adv Ther. 2016. PMID: 27287852 Review.

4

[Pharmacological and clinical profile of lansoprazole (Takepron IV injection 30 mg)].

Inatomi N, Nitta K, Sakurai Y. Inatomi N, et al. Nihon Yakurigaku Zasshi. 2008 Feb;131(2):149-56. doi: 10.1254/fpj.131.149. Nihon Yakurigaku Zasshi. 2008. PMID: 18277015 Review. Japanese. No abstract available.

5

[Pharmacological and clinical profiles of a novel potassium-competitive acid blocker, vonoprazan fumarate (Takecab(®) 10 mg and 20 mg)].

Matsukawa J, Inatomi N, Otake K. Matsukawa J, et al. Among authors: inatomi n. Nihon Yakurigaku Zasshi. 2015 Nov;146(5):275-82. doi: 10.1254/fpj.146.275. Nihon Yakurigaku Zasshi. 2015. PMID: 26558313 Review. Japanese. No abstract available.

6

Importance of desorption process from Abukuma River's suspended particles in increasing dissolved ¹³⁷Cs in coastal water during river-flood caused by typhoons.

Takata H, Wakiyama Y, Niida T, Igarashi Y, Konoplev A, Inatomi N. Takata H, et al. Among authors: inatomi n. Chemosphere. 2021 Oct;281:130751. doi: 10.1016/j.chemosphere.2021.130751. Epub 2021 May 11. Chemosphere. 2021. PMID: 34023762

7

High-throughput screening of potassium-competitive acid blockers.

Kondo M, Kawamoto M, Hasuoka A, Kajino M, Inatomi N, Tarui N. Kondo M, et al. Among authors: inatomi n. J Biomol Screen. 2012 Feb;17(2):177-82. doi: 10.1177/1087057111421004. Epub 2011 Sep 22. J Biomol Screen. 2012. PMID: 21940711

8

Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-ones as potassium-competitive acid blockers.

Imaeda T, Ono K, Nakai K, Hori Y, Matsukawa J, Takagi T, Fujioka Y, Tarui N, Kondo M, Imanishi A, Inatomi N, Kajino M, Itoh F, Nishida H. Imaeda T, et al. Among authors: inatomi n. Bioorg Med Chem. 2017 Jul 15;25(14):3719-3735. doi: 10.1016/j.bmc.2017.05.012. Epub 2017 May 6. Bioorg Med Chem. 2017. PMID: 28522264

9

[Pharmacological characteristics and clinical efficacies of a novel potassium-competitive acid blocker, vonoprazan fumarate].

Matsukawa J, Inatomi N, Nishida H, Tsukimi Y. Matsukawa J, et al. Among authors: inatomi n. Nihon Yakurigaku Zasshi. 2018;152(3):104-110. doi: 10.1254/fpj.152.104. Nihon Yakurigaku Zasshi. 2018. PMID: 30185727 Japanese.

10

The contribution of ¹³⁷Cs export flux from the Tone River Japan to the marine environment.

Takata H, Inatomi N, Kudo N. Takata H, et al. Among authors: inatomi n. Sci Total Environ. 2020 Jan 20;701:134550. doi: 10.1016/j.scitotenv.2019.134550. Epub 2019 Oct 24. Sci Total Environ. 2020. PMID: 31726417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results